Analytical Approaches for Assessing Curcumin and Nicotinamide Co-Encapsulated in Liposomal Formulation: UV Spectrophotometry and HPLC Validation

Ali Fahdawi; Naeem Shalan; Zainab Lafi; Omar Markab

doi:10.35516/jjps.v17i3.2359

Authors

Ali Fahdawi Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan
Naeem Shalan Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
Zainab Lafi Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
Omar Markab Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.

DOI:

https://doi.org/10.35516/jjps.v17i3.2359

Keywords:

Liposomes, Analytical Methods, UV Spectrophotometric, HPLC

Abstract

Background: The study presents two distinct analytical methods tailored for the precise determination of curcumin (CUR) and nicotinamide (NIC) within liposomal formulations, addressing the needs of researchers and analysts in the biomedical and food supplement sectors.

Method: UV spectrophotometry provides a swift and cost-effective solution for quantification, while High-Performance Liquid Chromatography (HPLC) offers enhanced specificity and sensitivity, particularly in complex matrices. Method validation, especially for HPLC, ensures reliability and suitability for rigorous analysis, advancing the field of Analytical Chemistry and strengthening development and quality assurance processes in the pharmaceutical and biotechnology industries.

Results: The encapsulation efficiencies of CUR and NIC into liposomes, primarily composed of DPPC and CHO, were found to be 30% ± 6% and 80% ± 5%, respectively. The developed analytical methods using UV spectrophotometry and reverse-phase HPLC demonstrated robustness and efficiency, allowing for the simultaneous analysis of CUR and NIC with high specificity, accuracy, and precision. Validation according to ICH Q2 guidelines revealed excellent system suitability, linearity, and robustness, with relative standard deviation consistently below 2%. Stability studies over three weeks at 4°C showed minimal changes in liposomal characteristics, indicating good stability. Furthermore, release studies at 37°C demonstrated enhanced solubility and increased release of curcumin, suggesting the potential of the liposomal formulation for drug delivery applications.

Conclusion: This study developed straightforward, time-efficient, and cost-effective analytical methods using UV spectrophotometry and reverse-phase HPLC to quantify CUR and NIC encapsulated in liposomal formulations.

References

Hussain Y, Alam W, Ullah H, Dacrema M, Daglia M, Khan H, et al. Antimicrobial Potential of Curcumin: Therapeutic Potential and Challenges to Clinical Applications. Antibiotics (Basel). 2022;11(3). DOI: https://doi.org/10.3390/antibiotics11030322

Homayoonfal M, Asemi Z, Yousefi B. Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis. Cellular & Molecular Biology Letters. 2022;27(1):21. DOI: https://doi.org/10.1186/s11658-022-00320-0

Lafi Z, Aboalhaija N, Afifi F. Ethnopharmacological importance of local flora in the traditional medicine of Jordan:(A mini review). Jordan Journal of Pharmaceutical Sciences. 2022;15(1):132-44. DOI: https://doi.org/10.35516/jjps.v15i1.300

Lafi Z, Alshaer W, Ma’mon MH, Zihlif MA, Asha NY, Abdelnabi H, et al. A review Echinomycin: A Journey of Challenges. Jordan Journal of Pharmaceutical Sciences. 2023;16(3):640-54. DOI: https://doi.org/10.35516/jjps.v16i3.918

Zargar A, Chang S, Kothari A, Snijders AM, Mao JH, Wang J, et al. Overcoming the challenges of cancer drug resistance through bacterial-mediated therapy. Chronic Dis Transl Med. 2019;5(4):258-66. DOI: https://doi.org/10.1016/j.cdtm.2019.11.001

Hashem S, Ali TA, Akhtar S, Nisar S, Sageena G, Ali S, et al. Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomedicine & Pharmacotherapy. 2022;150:113054. DOI: https://doi.org/10.1016/j.biopha.2022.113054

Giordano A, Tommonaro G. Curcumin and Cancer. Nutrients. 2019;11(10). DOI: https://doi.org/10.3390/nu11102376

Dai C, Lin J, Li H, Shen Z, Wang Y, Velkov T, et al. The Natural Product Curcumin as an Antibacterial Agent: Current Achievements and Problems. Antioxidants. 2022;11(3):459. DOI: https://doi.org/10.3390/antiox11030459

Hammad HM, Imraish A, Al-Hussaini M, Zihlif M, Harb AA, Abu Thiab TM, et al. Ethanol extract of Achillea fragrantissima enhances angiogenesis through stimulation of VEGF production. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2021;21(11):2035-42. DOI: https://doi.org/10.2174/1871530321666201230113018

Nikas IP, Paschou SA, Ryu HS. The Role of Nicotinamide in Cancer Chemoprevention and Therapy. Biomolecules. 2020;10(3). DOI: https://doi.org/10.3390/biom10030477

Peng M, Shi L, Ke S. Nicotinamide-based diamides derivatives as potential cytotoxic agents: synthesis and biological evaluation. Chemistry Central Journal. 2017;11(1):109. DOI: https://doi.org/10.1186/s13065-017-0338-5

Biniecka P, Matsumoto S, Belotti A, Joussot J, Bai JF, Majjigapu SR, et al. Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies. Molecules. 2023;28(4). DOI: https://doi.org/10.3390/molecules28041897

Nsairat H, Alshaer W, Lafi Z, Ahmad S, Al-Sanabrah A, El-Tanani M. Development and Validation of Reversed-Phase-HPLC Method for Simultaneous Quantification of Fulvestrant and Disulfiram in Liposomes. Bioanalysis. 2023;15(23):1393-405. DOI: https://doi.org/10.4155/bio-2023-0137

Teggar N, Bakchiche B, Abdel-Aziz ME-S, Bardaweel SK, Ghareeb MA. Chemical composition and biological evaluation of Algerian propolis from six different regions. Jordan Journal of Pharmaceutical Sciences. 2023:184-97. DOI: https://doi.org/10.35516/jjps.v16i2.1319

Yan Y, Liao Z, Shen J, Zhu Z, Cao Y. Nicotinamide potentiates amphotericin B activity against Candida albicans. Virulence. 2022;13(1):1533-42. DOI: https://doi.org/10.1080/21505594.2022.2119656

Sharma A, Chabloz S, Lapides RA, Roider E, Ewald CY. Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan. Nutrients. 2023;15(2):445. DOI: https://doi.org/10.3390/nu15020445

Liu P, Chen G, Zhang J. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules. 2022;27(4):1372. DOI: https://doi.org/10.3390/molecules27041372

Lafi Z, Alshaer W, Hatmal MM, Zihlif M, Alqudah DA, Nsairat H, et al. Aptamer-functionalized pH-sensitive liposomes for a selective delivery of echinomycin into cancer cells. RSC Adv. 2021;11(47):29164-77. DOI: https://doi.org/10.1039/D1RA05138E

Alshaer W, Zraikat M, Amer A, Nsairat H, Lafi Z, Alqudah DA, et al. Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: in vitro anti-proliferative and anti-invasive activity in glioblastoma. RSC advances. 2019;9(53):30976-88.

Nsairat H, Lafi Z, Al-Sulaibi M, Gharaibeh L, Alshaer W. Impact of nanotechnology on the oral delivery of phyto-bioactive compounds. Food Chemistry. 2023; 424: 136438. DOI: https://doi.org/10.1016/j.foodchem.2023.136438

Alshaer W, Zraikat M, Amer A, Nsairat H, Lafi Z, Alqudah DA, et al. Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: in vitro anti-proliferative and anti-invasive activity in glioblastoma. RSC Advances. 2019;9(53):30976-88. DOI: https://doi.org/10.1039/C9RA05636J

Pharmaceutical development. ICH Q8 (R2). 2009.